• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/99

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

99 Cards in this Set

  • Front
  • Back
cocaine MOA
Blocking reuptake of catecholamines and serotonin reuptake; blocks dopamine transporter (DAT) on nerve membrane
Cocaine pharmacologic effect
1) Initial: euphoria & increased arousal via increase in concentration of dopamine in synaptic cleft in the ventral striatum

2) following the "high" --> netagive feelings and dysphoria (D1 & D2 family receptors sequential)

3) "Crash" = fatigue, prolonged sleep, depression, increased appetite
Cocaine therapeutic uses
local anesthetic; topical for ear/nose/throat surgery
Cocaine Side effects
fatal arrhythmias, coronary vasospasm
Cocaine clearance
Spontaneous hydrolysis, plasma esterases, small hepatic contribution
Amphetamine MOA
1) Bind to the pre-synaptic membrane and induce release of neurotransmitter

2) Interact with dopamine containing synaptic vesicles, releasing free dopamine into the nerve terminal

3) Bind DAT, causing it to act in reverse and transport free dopamine out of the nerve terminal
Amphetamine pharmacologic use
delays eating (decreases hunger)
Amphetamine therapeutic use
Hyperactivity Attention deficit disorder
Narcolepsy
sleep disorders (Use as anorexigenic discontinued due to abuse potential)
Amphetamine side effects
High abuse potential
Psychosis resembling paranoid schizophrenia
increase BP, reflex bradycardia → risk of arrhythmia
Insomnia, nervousness, anorexia, GI pain, headache
Amphetamine clearance
primarily excreted unchanged by the kidney (approx
80%).
methamphetamine mOA
Increases release of DA & NE (& 5HT at high doses) by interacting w/ reuptake transporter to promote reverse transport from cytoplasm to synaptic cleft
Methamphetamine clearance
primarily excreted unchanged by the kidney (approx
80%).
methylphenidate street name
ritalin
methylphenidate MOA
Not well understood, blocks reuptake of dopamine via DAT as well as Norepi transporter
METHYLPHENIDATE pharmacalogic effects
Methylphenidate has strongest effects in prefrontal and perietal cortex, regions involved in attention and mental focus. These same regions are less active in ADHD individuals during attention tasks, and have even been reported to be shrunken in ADHD brains.
Methylphenidate therapeutic fxns
ADHD

Narcolepsy
Methyphenidate side effects
Intermediate abuse potential (greater in adults than kids)
Psychosis resembling paranoid schizophrenia
Insomnia, nervousness, anorexia, GI pain, headache
If you block the DAT receptor on mice, do they still like cocaine?
Yes! B/c cocaine (and other stimulants) are "dirty" drugs, meaning that they also effect serotonin & norepinephrine in addition to dopamine, so even if you block the DAT, they still have serotonin effects AND norepinephrine effects...

ergo, if you block both DAT & SERT (serotonin transporter) the preference is abolished
What is unique about mice w/ NET deletions when given cocaine
Mice w/ norepi transporter deletions are supersensitive to the locomotor activating effects of cocaine and amphetamine.
phentermine MOA
Increases release of DA and NE (& 5HT at high doses)
What is the order of "abuse potential" among drugs?
cocaine, amphetamine and methamphetamine (highest abuse potential)
>methylphenidate
> sibutramine and phentermine. (lowest)
What is phentermine's therapeutic use?
appetite suppressants (short term)
Phentermine's side effects?
Lower abuse potential
Sympathomimetic effects on heart – use caution in pts w/ hx of CV disease
sibutramine moa?
Blocking reuptake of catecholamines (NE & DA) and serotonin reuptake
Sibutramine uses?
Long term weight loss via active metabolites of CYP3A4
Sibutramine side effects?
Lower abuse potential
Sympathomimetic effects on heart – use caution in pts w/ hx of CV disease
caffeine MOA
competitive antagonism at adenosine receptors

Reduces resting cerebral blood flow

generally disinhibits neuronal activity
What is methylxanthine
Caffiene
Caffeine clinical uses?
Used in patients with asthma as a bronchodilator
Use in the US has now been markedly curtailed since the development of beta-agonists, inhaled corticosteroids, and leukotriene antagonists.


--> off label: Sleep apnea in neonatal units accompanied by bradycardia
Caffeine pharmalogical effects?
CAFFIENE together Binds to receptors and is antagonistic--> prevents ADENOSINE FROM BINDING AND ACTIVATING SIGNAL
--> adenosine REDUCES presynaptic release and stabilize NMDA blockade post synpatically, ergo
Caffiene induces synaptic release and reduce magnesium blockade --> disinhibit synaptic transmission --> central nervous effects --> increased neuronal activity

Systemic: increases electrical impulses and pacemaker function of cardio myocytes (heart fxn & rate!)
What is the order of "abuse potential" among drugs?
cocaine, amphetamine and methamphetamine (highest abuse potential)
>methylphenidate
> sibutramine and phentermine. (lowest)
What is phentermine's therapeutic use?
appetite suppressants (short term)
Phentermine's side effects?
Lower abuse potential
Sympathomimetic effects on heart – use caution in pts w/ hx of CV disease
sibutramine moa?
Blocking reuptake of catecholamines (NE & DA) and serotonin reuptake
Sibutramine uses?
Long term weight loss via active metabolites of CYP3A4
Sibutramine side effects?
Lower abuse potential
Sympathomimetic effects on heart – use caution in pts w/ hx of CV disease
caffeine MOA
Inhibitor of cyclic nucleotide phosphodiesterases and adenosine receptor antagonists, the latter is believed to be the principal contributor to CNS stimulant effects.

Reduces resting cerebral blood flow

generally disinhibits neuronal activity
What is methylxanthine
Caffiene
Caffeine clinical uses?
Used in patients with asthma as a bronchodilator
Use in the US has now been markedly curtailed since the development of beta-agonists, inhaled corticosteroids, and leukotriene antagonists.


--> off label: Sleep apnea in neonatal units accompanied by bradycardia
Caffeine pharmalogical effects?
CAFFIENE together Binds to receptors and is antagonistic--> prevents ADENOSINE FROM BINDING AND ACTIVATING SIGNAL
--> adenosine REDUCES presynaptic release and stabilize NMDA blockade post synpatically, ergo
Caffiene induces synaptic release and reduce magnesium blockade --> disinhibit synaptic transmission --> central nervous effects --> increased neuronal activity

Systemic: increases electrical impulses and pacemaker function of cardio myocytes (heart fxn & rate!)
Caffeine elimination?
hepatic metabolism.
Caffeine side effects?
Tolerance develops to the stimulating effects
Withdrawal syndrome can be identified
Fatigue
Sedation
Headache and nausea (with chronic, high-dose use)
modafinil MOA?
Mechanism is unknown, but thought:

Interactions with both dopaminergic and noradrenergic systems have been postulated

There are indications that it both inhibits hypothalamic sleep-promoting neurons, and activates pathways promoting wakefulness.
Modafinil therapeutic uses?
Narcolepsy
Obstructive sleep apnea
Shift work sleep disorder

Increased daytime wakefulness produced by modafinil is not followed by a rebound increase in nonREM sleep.
Positives of Modafinil?
It has a much lower incidence of stimulant side effects than other drugs
Appears less subject to abuse
Does not produce the same degree of symapthomimetic effects as do ampehetamines
Modafinil side effects?
High (2x recommended) doses were observed to cause a 9 bpm increase in heart rate and a small increase in BP in healthy subjects.
Caution is advised in patients with cardiovascular problems:
MI
Unstable angina
Left ventricular hypertrophy.

CAUSES STEVEN JOHNSON SYNDROME!!!

Psych: anxiety, mania, suicidal thinking
Modafinil metabolism?
Metabolism (CYP3A4, some enzyme induction)
LSD moa
5HT2-A partial agonist
Also enhances glutamate
LSD pharmacologic side effects?
Hallucinations: synesthesias, dilation of time
Euphoria; or “bad trips”
Peripheral sympathomimetic signs: increase HR & BP, mydriasis
Tolerance, but no withdrawal

LSD only:
Hallucinogen persisting perception disorder (flashbacks)
What gives you auditory hallucinations?
PCP
LSD MOA
5HT2-A partial agonist

5-HT2A activation leads to excitation, in part via enhancement of glutamate actions.
Are all 5-HT2A agonists hallucinoenics?
No. Different agonists at the same receptor may couple to different effector systems.
What is the only hallucinogenic that gives you flashbacks?
LSD
What are physical effects of LSD?
dilated pupils
higher body temperature and sweating
nausea and loss of appetite
increased blood sugar
Increased heart rate and blood pressure
Sleeplessness
dry mouth and tremors
What is appearance of LSD?
odorless
colorless
slightly bitter
At what doses do LSD produce psychogenic effects?
less than 100mg
Does LSD have withdrawal symptoms?
no & its not toxic in the human brain
Mescaline MOA
5HT2-A partial agonists
Mescaline effects
same as LSD
4methylenedioxyamphetamine street name
Ecstasy
4methylenedioxyamphetamine MOA?
5HT2-A partial agonist

5-HT2A activation leads to excitation, in part via enhancement of glutamate actions.
4methylenedioxyamphetamine side effects?
Hallucinations: synesthesias, dilation of time
Euphoria; or “bad trips”
Peripheral sympathomimetic signs: increase HR & BP, mydriasis
Tolerance, but no withdrawal

MDMA only:
serotonergic neuron degeneration****
MDMA effects
same as LSD

User experiences:
extreme changes in mood
several different emotions at once
swing rapidly from one emotion to another
delusions and visual hallucinations
Physical effects
dilated pupils
higher body temperature and sweating
nausea and loss of appetite
increased blood sugar
Increased heart rate and blood pressure
Sleeplessness
dry mouth and tremors
PCP moa
Glutamate antagonist!

(Non-competitive antagonist at NMDA receptors)

// schizophrenia
PCP effects
PCP can cause visual and AUDITORY hallucinations.
Users commonly exhibit:
Hostile and combative behavior
Paranoid delusions
May be numb and not feel pain
Tachycardia
Hypertension
Sweating
**Anesthetic effects can ensue at higher doses

**Users can progress from agitated behavior with elevated blood pressure, to coma with paralytic dilation of the pupils.
marijuana MOA
Δ-9 tetrahydro-cannabinol (delta-9-THC) is the active ingredient – acts as cannabinoid receptor partial agonist (mainly CB1, but also CB2)
Marijuana therapeutic uses?
Recreational drug
Analgesia
Appetite stimulation
Anti-nausea
Reduction of intraocular pressure
Decrease spasticity in MS pts
receptor C1 sites of action and action?
Found throughout the brain
Highest amounts in:
Basal ganglia
Cerebellum
Hippocampus
Cerebral cortex
Also in:
Spinal cord
Hypothalamus
Thalamus
Peripheral nerve terminals
Testes
CB1 MOA
The CB1 receptor couples to Gi/o and its activation:
Inhibits adenylyl cyclase
Inhibits neuronal Ca+2 channels
Increases K+ conductance
Where is CB2 found?
CB2 receptor is found in the periphery on immune system cells (lymphocytes, macrophages) and in the CNS on microglia.
Marijuana effects?
Psychological effects may include:
Euphoric mellow
High and giddiness
Anxiety
Panic (especially with high doses)
Time dilation
Cognitive and psychomotor impairment ( which may persist beyond the perceived high).

also...

Analgesia
Appetite stimulation
Antinauseant action
Reduction of intraocular pressure
Reduction in spasticity in patients with multiple sclerosis
marijuana clearance
Hepatic metabolism (note: metabolites detectable in urine/feces up to 5 weeks post-use)
Delta-9 tetrahydrocannabinol (Delta-9-THC)

MOA?
Δ-9 tetrahydro-cannabinol (delta-9-THC) is the active ingredient –
acts as cannabinoid receptor partial agonist (mainly CB1, but also CB2)
Dronabinol MOA
Δ-9 tetrahydro-cannabinol (delta-9-THC) is the active ingredient –
acts as cannabinoid receptor partial agonist (mainly CB1, but also CB2)
Do Cannabinoids cause dependence?
No. Most likely because of their long half life (1.5 days)
How do endocannabinoids differ from classical neurotransmitter?
1) not synthesized and stored in nerve terminals, and then released when an action potential invades the terminal.

2)depolarization of a post-synaptic cell and the entry of Ca2+, or activation of G-protein coupled glutamate receptors (mGluR) activates enzymes that synthesize endocannabinoids from phospholipids.
How are endocannabinoids scaled down?
C1 receptors are also on the presynaptic cleft, ergo they can diffuse back across synatpic cleft to act presynaptically -->inhibits presynaptic terminal to scale down activation
What are signs of precipitated withdrawal from cannabinoids in humans?
Restlessness
Irritability
Agitation
Insomnia
Nausea
GI cramps
What are side effects of inhalents?
Euphoria
Intoxication (exacerbated by hypoxia and hypercapnea when bagging)
Drowsiness
Slurred speech
Ataxia
Disorientation
Hallucinations
Seizures
Coma
What is mescaline MOA?
Phenethylamine derivative
5HT2-A partial agonist
Also enhances glutamate

-->similar to LSD, causes hallucinations, etc
What is unique about MDMA compared to other Phenethylamine derivative
5HT2-A partial agonist?
It has serotonergic neuron degeneration
What is dronabinol?
ingredient –
acts as cannabinoid receptor partial agonist (mainly CB1, but also CB2)


//marijuana
What is acetazolamide? what is its MOA? Where does it work?
Carbonic Anhydrase Inhibiting Diuretics

What: Carbonic anhydrase inhibitor.
Where: Proximal convoluted tubule.
How: Increases solute load in urine by ↓ reabsorption of NaHCO3.
What is pharmacalogic effect of acetazolamide?
Net result:
↑ excretion of Na+, K+, HCO3-, phosphate;
↓ excretion of H+ (↑ urine pH).

Self-limiting!: Causes metabolic acidosis; also macula densa senses ↑ Na+ in urine → afferent arteriole constriction → ↓GFR.
Note: 100% bioavailability.
Therapeutic uses for acetazolamide?
*Edema (not 1st line)
*Ocular hypertension (open angle)
*Prophylaxis for acute altitude sickness
*Epilepsy (mainly absence seizures in adults—metabolic acidosis suppresses CNS)
*Correct alkalosis
Side effects of acetazolamide?
Hypersensitivity (due to sulfa structure): bone marrow depression, skin rxn, renal lesions.

Overdose: somnolence, paresthesias.

Alkalization of urine:
*ammonia retention → contraindicated in hepatic cirrhosis/
encephalopathy
*precipitation of Ca-phosphate salts →contraindicated in renal stones
*worsens preexisting acidosis → contraindicated in hyperchloremic acidosis & severe COPD
*↓ urine excretion of weak bases → drug interactions
Elimination of acetazolamide?
F = 100%,
elimination--renal
t1/2 = 6-9 hrs.
What is dorzolamide?
Carbonic anhydrase inhibitor:

Where: Proximal convoluted tubule.
How: Increases solute load in urine by ↓ reabsorption of NaHCO3.
What is mannitol? Where does it work and what is its MOA?
What: Osmotic diuretic.
Where: Thin descending limb.
How: Given in large doses, are freely filtered but undergo limited reabsorption → ↑ solute load in lumen → ↓water reabsorption.
What is pharmacologic effect of mannitol? (i.e. excretion, absorption)
Net result: ↑ excretion of nearly all electrolytes (Na+, K+, Ca++, Mg++, Cl-, HCO3-, phosphate)
What is/are therapautic use for mannitol?
*Acute renal failure—prevention & tx (controversial)
*Dialysis disequilibrium (hypoosmolarity of extracellular fluid)
*Ocular hypertension*** closed!
*Intracranial pressure*****
*Estimate GFR
*↑renal excretion of toxic
Side effects of mannitol?
Expansion of extracellular fluid:
*hyponatremia → headache, nausea, vomiting
*contraindicated in heart failure, pulmonary congestion

Overdiuresis → hypernatremia, dehydration

Contraindicated w/ intracranial bleeding!!!!
pharmokinetics of mannitol?
F = 100%,
elimination--renal
t1/2 =VERY SHORT
What is mannitol's effect on the gradient?
Washes out medullary gradient --> less impact from ADH --> less resorption of water
Explain furomeside what type of drug is it? where does it act and how?
What: Loop diuretic.
Where: Thick ascending limb.
How: Inhibits Na/K/2Cl symporter →

IMPORTANT: acutely increases systemic venous capacitance (via a renally derived mediator, PGs?) and thus decreases cardiac preload and may reduce pulmonary edema even before diuresis occurs.--> FEEL BETTER BEFORE THEY EVEN GET A DROP OF URINE OUT!
Pharmacologic effects of furomeside?
1) ↓positive potential in lumen, so ↑Ca++ & Mg++ excretion;

2) ↓ NaCl in renal medulla → ↓ medullary osmotic gradient → ↓ ability to concentrate urine

3) Blocks NaCl transport into macula densa, so GFR doesn't ↓

ALSO: furosemide has venodilator action that can ↓ dyspnea by ↓ preload
Uses for furomeside?
1. Acute pulmonary edema

2 Edema associated with heart failure, cirrhosis, renal failure

3. Hypertension

4. Hypercalcemia--a classic use, but minimal supporting

5. A classic use has been in acute renal failure to convert oliguric to nonoliguric status. This use is not supported by recent meta-analyses—use of furosemide does not improve mortality or decrease the need for transplant or dialysis, and may cause ototoxicity.
Side effects of furomeside?
↑systemic venous capacitance → ↓cardiac preload, ↓pulmonary edema

*Hypotension, reduced GFR, circulatory collapse
*Hyponatremia
*Hypokalemia --> arrythmias!
*Metabolic alkalosis (losing H+)
*Hypomagnesia
*OTTOTIXICITY!!!
*Hyperuricemia
*increased LDL: HDL & glucose intolerance
*Hypersensitivity!
Pharmokinetics of furomeside?
RENAL & short half life!

WORK, obviously, from the luminal side of the tubule, and because they are highly bound to plasma proteins must be transported by the proximal tubule organic acid transporter.